Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorPartridge, Ann H.
dc.contributor.authorNiman, Samuel M.
dc.contributor.authorRuggeri, Monica
dc.contributor.authorPeccatori, Fedro A.
dc.contributor.authorAzim Jr., Hatem A.
dc.contributor.authorColleoni, Marco
dc.contributor.authorSaura Manich, Cristina
dc.date.accessioned2022-04-22T12:53:10Z
dc.date.available2022-04-22T12:53:10Z
dc.date.issued2021-10
dc.identifier.citationPartridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA, Colleoni M, et al. Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy. Breast. 2021 Oct;59:327–38.
dc.identifier.issn0960-9776
dc.identifier.urihttps://hdl.handle.net/11351/7371
dc.descriptionCàncer de mama; Desig d'embaràs; Dones joves
dc.description.sponsorshipThe POSITIVE trial and this work are sponsored by the IBCSG in non-North American countries and by the Alliance for Clinical Trials in Oncology in North America, with collaboration of the Breast International Group (BIG) cooperative groups and US National Clinical Trials Network groups.
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesThe Breast;59
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectHormonoteràpia
dc.subjectEmbaràs
dc.subjectMama - Càncer
dc.subject.meshCancer Survivors
dc.subject.meshHormones
dc.subject.mesh/therapeutic use
dc.subject.meshPregnancy
dc.titleWho are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.breast.2021.07.021
dc.subject.decssupervivientes de cáncer
dc.subject.decshormonas
dc.subject.decs/uso terapéutico
dc.subject.decsembarazo
dc.relation.publishversionhttps://doi.org/10.1016/j.breast.2021.07.021
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Partridge AH] Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. [Niman SM] International Breast Cancer Study Group Statistical Center, Department of Data Science, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA. [Ruggeri M] International Breast Cancer Study Group, Program for Young Patients, Coordinating Center, Bern, 3008, Switzerland. [Peccatori FA] Fertility and Procreation Unit, Gynecologic Oncology Program, European Institute of Oncology IRCCS, Milan, 20141, Italy. [Azim HA] Breast Cancer Center, Hospital Zambrano Hellion, School of Medicine, Tecnologico de Monterrey, San Pedro Garza Garcia, 66278, Mexico. [Colleoni M] International Breast Cancer Study Group, Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy. [Saura C] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.identifier.pmid34390999
dc.identifier.wos000696705600040
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple